Antibiotic resistance is a leading health threat, and whole genome sequencing is the most accurate way to study pathogens. We make it easier to understand, detect and prevent the spread of antibiotic resistance.
Employees: 1-10
Total raised: $1.1M
Investors 1
| Date | Name | Website |
| - | Wave Ventu... | wave.ventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.06.2023 | - | $1.1M | - |
Mentions in press and media 4
| Date | Title | Description |
| 16.06.2023 | Finland's Solu raises €1 million, partners with Stanford and plans a pathogen DNA library to speed up the identification of antibiotic resistance | Finnish biotech start-up Solu has raised €1 million in funding to fuel the development and commercialisation of its product as it plans to builds an extensive pathogen DNA library. Antibiotic resistance is a major concern world wide, and it... |
| 15.06.2023 | Finnish biotech Solu raises €1M to deal with antibiotic resistance | Finnish biotech Solu raises €1M to deal with antibiotic resistance 15 June, 2023, 11:34 Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> --> Helsinki-based biotech startup Solu ... |
| 15.06.2023 | Solu Raises €1M in Funding | Solu, a Helsinki, Finland-based biotechnology company focusing on combating antibiotic resistance, raised €1M in funding. The round was led by Lifeline Ventures with participation from Wave Ventures. The company intends to use the funds to ... |
| - | Solu | “Discover the next generation toolkit for analyzing, storing and sharing bacterial genomes.” |